Expert commentators

Advice

The following clinicians contributed to this briefing:

Dr Keith Girling, medical director, Nottingham University Hospitals NHS Trust, did not declare any interests.
Dr Matt Inada-Kim, consultant acute physician and sepsis lead, Hampshire Hospitals NHS Foundation Trust, national clinical lead for deterioration and national clinical adviser for sepsis at NHS England and NHS Improvement, declared that he has authored 4 recent papers and 2 NHS England blogs that may be or may have been previously used by NICE.
Dr Tanya Pankhurst, deputy director of digital healthcare, University Hospitals Birmingham NHS Foundation Trust, declared that her trust builds, uses and now markets this technology through a third party, but she does not have any personal shares or other commercial interest in the technology.
Dr Emmanuel Nsutebu, consultant infectious diseases physician, Royal Liverpool and Broadgreen University Hospitals NHS Trust, did not declare any interests.
Ingrid O'Neil, sister (retired), critical care outreach, The Newcastle upon Tyne Hospitals NHS Foundation Trust, did not declare any interests.
Dr Phil Laws, consultant in intensive care medicine, clinical director of quality and safety, and NEWS champion, The Newcastle upon Tyne Hospitals NHS Foundation Trust, did not declare any interests.
Dr Richard M Venn, consultant anaesthesia and intensive care, Western Sussex Hospitals NHS Foundation Trust, declared that he holds grants from the Small Business Research Initiative and managed by the National Institute for Health Research Devices for Dignity Healthcare Technology Co-operative (NIHR Devices for Dignity HTC) and the British Kidney Foundation.
Melanie Palmer, senior sister, critical care outreach, The Newcastle upon Tyne Hospitals NHS Foundation Trust, did not declare any interests.